Non-thyroidal illness syndrome and short-term survival in a hospitalised older population

Age Ageing. 2010 Jan;39(1):46-50. doi: 10.1093/ageing/afp197. Epub 2009 Nov 16.

Abstract

Background: non-thyroidal illness syndrome (NTIS) has been associated with an adverse clinical outcome.

Objective: to evaluate the prevalence of NTIS, its impact on patients' survival and the possible pathogenic role of systemic inflammation.

Design: observational cross-sectional analysis.

Participants and setting: three hundred and one acutely ill older patients (156 women; median age 81 years, range 65-101) consecutively admitted to a primary care unit.

Methods: serum FT(3), FT(4) and thyrotropin levels as well as acute inflammation indexes were evaluated.

Results: the NTIS prevalence (specifically low T3 syndrome) was 31.9%. A significant association was found between NTIS and acute renal failure (P = 0.006), New York Heart Association classification (NYHA) IV heart failure (P = 0.003) and metastasised cancer disease (P = 0.0002). Serum FT(3) values correlated inversely with serum C-reactive protein (P < 0.0001), lactate dehydrogenase (P = 0.0004), fibrinogen (P = 0.03) and erythrocyte sedimentation rate (P < 0.0001) values, and progressively decreased with increasing tertiles of age (P = 0.0004). The mortality rate was significantly higher (P = 0.0002) among patients with low T3 syndrome, which emerged as the sole predictive factor of death (odds ratio 4.3; 95% confidence interval 1.7-10.5).

Conclusions: low T3 syndrome is very common in the hospitalised older population, emerging as the most sensitive independent predictor of short-term survival. Serum FT(3) determination should be included in the assessment of short-term prognosis of acutely ill older patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / mortality
  • Cross-Sectional Studies
  • Euthyroid Sick Syndromes / blood
  • Euthyroid Sick Syndromes / epidemiology
  • Euthyroid Sick Syndromes / mortality*
  • Female
  • Humans
  • Length of Stay
  • Male
  • Prevalence
  • Prognosis
  • Respiration, Artificial / mortality
  • Risk Factors
  • Survival
  • Thyrotropin / blood
  • Time Factors
  • Treatment Outcome

Substances

  • Thyrotropin